Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting (Q82037910)
Jump to navigation
Jump to search
scientific article published on 01 December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting |
scientific article published on 01 December 2005 |
Statements
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting (English)
William J Valentine
Andrew J Palmer
Morten Lammert
Lars Nicklasson
Volker Foos
Stéphane Roze
1 December 2005